CT and MR imaging findings in patients with acquired heart disease at risk for sudden cardiac death

Radiographics

Volumn 29, Issue 3, 2009, Pages 805-823

  Sparrow, Patrick J ^a   Merchant, Naeem ^a   Provost, Yves L ^a   Doyle, Deirdre J ^a   Nguyen, Elsie T ^a   Paul, Narinder S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; FEMALE; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; INFANT; MALE; MIDDLE AGED; MYOCARDITIS; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRESCHOOL CHILD; RADIOGRAPHY; REVIEW; RISK; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; FEMALE; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDITIS; RISK; TOMOGRAPHY, SPIRAL COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 68549104487     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.293085715     Document Type: Article

References (59)

1. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993;119: 1187-1197.
2. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. Philadelphia, Pa: Saunders, 2001.
3. Centers for Disease Control and Prevention (CDC). State-specific mortality from sudden cardiac death: United States, 1999. MMWR Morb Mortal Wkly Rep 2002;51:123-126.
4. Kirchhof P, Breithardt G, Eckardt L. Primary prevention of sudden cardiac death. Heart 2006;92: 1873-1878.
5. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163.
6. Doolan A, Langlois N, Semsarian A. Causes of sudden cardiac death in young Australians. Med J Aust 2004;180:110-112.
7. Wisten A, Forsberg H, Krantz P, Messner T. Sudden cardiac death in 15-35-year olds in Sweden during 1992-1999. J Intern Med 2002;252:529-536.
8. Sparrow P, Merchant N, Provost Y, Nguyen E, Doyle D, Paul N. MRI and CT of inheritable and congenital conditions associated with sudden cardiac death. Eur Radiol 2009;19(2):259-270.
9. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80: 10F-19F.
10. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 1998;97:1514-1521.
11. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
12. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003;24:13-15.
13. Davies MJ. Anatomic features in victims of sudden coronary death: coronary artery pathology. Circulation 1992;85(1 suppl):I19-I24.
14. Gaemperli O, Valenta I, Schepis T, et al. Coronary 64-slice CT angiography predicts outcome in patients with known or suspected coronary artery disease. Eur Radiol 2008;18:1162-1173.
15. Caussin C, Ohanessian A, Ghostine S, et al. Characterization of vulnerable nonstenotic plaque with 16-slice computed tomography compared with intravascular ultrasound. Am J Cardiol 2004;94:99-104.
16. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002;105:939-943.
17. Schoenhagen P, Ziada KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000;101:598-603.
18. Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol 1979;44:39-45.
19. Roberts WC. Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaque in the major epicardial coronary arteries at necropsy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and unstable angina pectoris. Am J Cardiol 1989;64:324-328.
20. Warnes CA, Roberts WC. Sudden coronary death: relation of amount and distribution of coronary narrowing at necropsy to previous symptoms of myocardial ischemia, left ventricular scarring and heart weight. Am J Cardiol 1984;54:65-73.
21. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three vessel intravascular ultrasound study. Circulation 2002;106:804-808.
22. Nanthakumar K, Epstein AE, Kay GN, et al. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004;44:2166-2172.
23. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
24. Bello D, Fieno D, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005; 45:1104-1108.
25. Bolick DR, Hackel DB, Reimer KA, Ideker RE. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation 1986;74:1266-1279.
26. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580.
27. Gowda RM, Sacchi TJ, Khan IA. Clinical perspectives of the primary spontaneous coronary artery dissection. Int J Cardiol 2005;105:334-336.
28. Park SM, Koh KK, Kim JH, Yoon KH, Chung WJ, Kang WC. Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography. Int J Cardiol 2008;127:e73-e75.
29. Chabrot P, Motreff P, Boyer L. Postpartum spontaneous coronary artery dissection: a case of pseudoaneurysm evolution detected on MDCT. AJR Am J Roentgenol 2006;187:W660.
30. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-842.
31. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated car-diomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59.
32. Bello D, Shah DJ, Farah GM. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-1953.
33. Assomull RG, Prasad SK, Lynne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48: 1977-1985.
34. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
35. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-2825.
36. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-1398.
37. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68:1388-1392.
38. Theleman KP, Kuiper JJ, Roberts WC. Acute myocarditis (predominately lymphocytic) causing sudden death without heart failure. Am J Cardiol 2001;88:1078-1083.
39. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99:1091-1100.
40. Hauck AJ, Kearney DL, Edwards WD. Evaluation of post mortem endomyocardial biopsy specimens from 38 patients with lymphotrophic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-1245.
41. Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006;48:2085-2093.
42. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast mediaenhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1809.
43. Brooks MA, Sane DC. CT findings in acute myocarditis: 2 cases. J Thorac Imaging 2007;22:277-279.
44. Dambrin G, Laissy JP, Serfaty JM, Caussin C, Lancelin B, Paul JF. Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis: a preliminary comparative study with cardiac MRI. Eur Radiol 2007;17:331-338.
45. Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 1994;128: 301-307.
46. Mady C, Ianni BM, Arteaga E, et al. Relation between interstitial myocardial collagen and the degree of clinical impairment in Chagas' disease. Am J Cardiol 1999;84:354-356.
47. Rochitte CE, Oliviera PF, Andrada JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of severity. J Am Coll Cardiol 2005;46:1553-1558.
48. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-172.
49. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108.
50. Hiraga H, Yuwai K, Hiroe M, et al. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases from the Japanese Ministry of Health and Welfare. Tokyo, Japan: Japanese Ministry of Health and Welfare, 1993; 23-24.
51. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58:1204-1211.
52. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110: 520-527.
53. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadoliniumenhancement cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-1690.
54. Kanao S, Tadamura E, Yamamuro M, et al. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging. J Comput Assist Tomogr 2005;29:745-748.
55. Smedema JP, Truter R, de Klerk PA, Zaaiman L, White L, Doubell AF. Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography. Int J Cardiol 2006;112:261-263.
56. Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007;50: 2101-2110.
57. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol 1984;3:107-113.
58. Falk RH, Plehn JF, Deering T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987;59:418-422.
59. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193.